Home General Biotechnology Drug Patent Expirations in February 2012

Drug Patent Expirations in February 2012

Drug Patent Expirations in February 2012

*Drugs may be covered by multiple patents

TradenameApplicantGeneric NamePatent NumberPatent Expiration
VISUDYNEQltverteporfin6,074,666Feb 5, 2012
GANIRELIX ACETATE INJECTIONOrganon Usa Incganirelix acetate4,801,577Feb 5, 2012
ALINIARomarknitazoxanide5,387,598Feb 7, 2012
AZILECTTevarasagiline mesylate5,786,390Feb 7, 2012
AZILECTTevarasagiline mesylate5,387,612Feb 7, 2012
AZILECTTevarasagiline mesylate5,457,133Feb 7, 2012
LOVENOXSanofi Aventis Usenoxaparin sodiumRE38743Feb 14, 2012
LOVENOX (PRESERVATIVE FREE)Sanofi Aventis Usenoxaparin sodiumRE38743Feb 14, 2012
LOVENOX (PRESERVATIVE FREE)Sanofi Aventis Usenoxaparin sodium5,389,618Feb 14, 2012
LOVENOXSanofi Aventis Usenoxaparin sodium5,389,618Feb 14, 2012
ACANYADow Pharm Scibenzoyl peroxide; clindamycin phosphate6,117,843Feb 18, 2012
OPTISONGe Healthcarealbumin human5,558,094Feb 28, 2012

This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin.

Courtesy of DrugPatentWatch.com

NO COMMENTS

  1. I wonder how 12 patents/mo. compares to previous years? I am assuming it is a relatively high number considering how 2012 has been reported to be a big year in patent expiration..

Leave a Reply